Safeguard Scientifics Appoints Gary J. Kurtzman, MD, as Vice President of Life Sciences

Strategic Insights

Jul 2, 2006 — 1 min read

Safeguard Scientifics, Inc. has appointed Gary J. Kurtzman, MD, as its new vice president of life sciences. In this role, Kurtzman will focus on partnering with entrepreneurial companies in the life sciences sector, including medical devices, diagnostics, specialty pharmaceuticals, and technology-related services. He will also support Safeguard's existing partner companies in developing and launching biopharmaceutical products and services.

Key Takeaways:

Gary J. Kurtzman, MD, has been appointed as the vice president of life sciences at Safeguard Scientifics, Inc.
Kurtzman will be responsible for identifying and partnering with entrepreneurial companies in the life sciences sector, including medical devices, diagnostics, specialty pharmaceuticals, and technology-related services.
He will also assist Safeguard's existing partner companies in developing, launching, and optimizing their biopharmaceutical products and services.
Safeguard's partner life science companies include Clarient, Inc., Laureate Pharma, Inc., Neuronyx, Inc., and Ventaira Pharmaceuticals, Inc.
Kurtzman has a background in biopharmaceutical development and life sciences investing, having previously worked at BioAdvance and Pluvita Corporation.
He has authored over 40 research articles and book chapters and holds 12 issued United States patents.
Kurtzman will continue to serve on academic and biomedical committees and boards.

Statistics:

Over 40 research articles, book chapters, and reviews authored by Gary J. Kurtzman, MD.
12 issued United States patents held by Gary J. Kurtzman, MD.
Clarient, Inc. is a cancer diagnostics company that is one of Safeguard's partner life science companies.
Laureate Pharma, Inc. is a bioprocessing manufacturing outsourced services provider that is also one of Safeguard's partner companies.

Sources:

Health & Medicine Week editors, "Gary J. Kurtzman, MD, Appointed Vice President of Life Sciences at Safeguard Scientifics, Inc.", Health & Medicine Week, (undated).
NewsRx.com, "Safeguard Scientifics Appoints Gary J. Kurtzman as Vice President of Life Sciences", NewsRx.com, (2006).

The End of American Hypergrowth

For two centuries, the US economy grew by adding workers. That's over.

Healthcare's $5.3 Trillion Drag

How Medical Spending Became America's Biggest Productivity Tax

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Researchers at the Wuhan University of Technology in China have made significant progress in the field of nanotechnology, specifically in the area of nanoindentation. A novel electromagnetic shock treatment (EST) method has been developed to enhance the microscale mechanical properties of a titanium alloy, with promising results obtained through array-based

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients

Research investigators at the Zhengzhou Central Hospital Affiliated to Zhengzhou University have made groundbreaking discoveries on the role of gut microbiota in determining the efficacy of immunotherapy for colon cancer patients. The study, which was recently published in Biochimica et Biophysica Acta, reveals that specific bacterial species and microbial metabolites

Read more

The End of American Hypergrowth

Healthcare's $5.3 Trillion Drag

Breakthrough in Nanotechnology: Electromagnetic Shock Treatment Shows Promise

Gut Microbiota Plays Crucial Role in Immunotherapy Success for Colon Cancer Patients